221195-30-8

Basic information

• Product Name: Benzenenonanal
• CAS NO: 221195-30-8
• Molecular Formula: C15H22O
• Molecular Weight: 218.339
• Mol File: 221195-30-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzenenonanal(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenenonanal(221195-30-8)
• EPA Substance Registry System: Benzenenonanal(221195-30-8)

Safety Data

• Hazardous Substances Data: 221195-30-8(Hazardous Substances Data)

Upstream product

• 104-53-0 3-phenyl-propionaldehyde 
• 16269-06-0 9-phenylnonanoic acid 
• 928753-93-9 (5-carboxypentyl)triphenylphosphonium bromide 
• 6654-36-0 methyl 6-oxohexanoate 
• 3208-26-2 9-phenyl-1-hydroxynonane 
• 4547-43-7 methyl 6-hydroxycaproate 
• 502-44-3 hexahydro-2H-oxepin-2-one 
• 3208-25-1 7-phenylheptan-1-ol 
• 260050-22-4 methyl 9-phenyl-2(E)-nonenoate 
• 260050-21-3 (E)-methyl 7-phenylhept-2-enoate 
• 101689-18-3 7-phenylheptanoic acid methyl ester 
• 121784-15-4 7-phenylheptanal 
• 36884-28-3 5-phenyl-1-pentanal 
• 2270-20-4 5-Phenylpentanoic acid 

Downstream Products

• 1403823-20-0 (S)-6-((9-phenylnonyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol 
• 82427-57-4 11-phenyl-1-(2',6'-dihydroxyphenyl)-undecan-1-one 
• 260050-37-1 5-(8-phenyl-octyl)-4-tosyl-2-oxazoline 
• 221195-27-3 1-(6-benzyloxy-2-hydroxyphenyl)-3-hydroxy-11-phenylundecan-1-one 

Relevant articles and documents

DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)

This present disclosure relates to protein kinase C (PKC) modulating compounds, methods of treating a subject with cancer using the compounds, and combination treatments with a second therapeutic agent.

Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles.

The influence of lipophilic moieties attached to a 4-1H-imidazole ring on the histamine H3 receptor activity was systematically investigated. Series of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles were prepared, with an alkyl chain varying from 2-9 methylene groups and from 1-9 methylene groups, respectively. The compounds were tested for their activity on the H3 receptor under in vitro conditions. For the 4-(n-alkyl)-1H-imidazoles the activity is proportional to chain length, ranging from a pA2 value of 6.3 +/- 0.2 for 4-(n-propyl)-1H-imidazole to a pA2 value of 7.2 +/- 0.1 for 4-(n-decyl)-1H-imidazole. For the series 4-(omega-phenylalkyl)-4H-imidazoles an optimum in H3 activity was found for the pentylene spacer: 4-(omega-phenylpentyl)-1H-imidazole has a pA2 value of 7.8 +/- 0.1.